Member Info for Bella6532

Fatbanker...no need for that hun...pour a cold one instead...

Fatbanker...if you scroll down to Jupiter and click on their name it opens a history page which show how much they made/lost on close outs. Avacta is at the op showing zero history. If you scroll down to the bottom of this history page you will see Avacta listed at .88% and the word ongoing.

Haha...wow! Where did the week go...you're right Energyshares think it's time to crack open a long neck...

Oh there they go again another UT at 52.5 so again tomorrow will look like we open down again to scare the uninitiated into selling or help keep a cap on the SP. Looks like they're struggling to get hands on shares in volume.

Nothing missed, just a very quiet day...

A couple of interesting points about Jupiters short.
They have reported 7 times since 7 July 2021. The first being 0.52% but Short T doesn't show less than 0.5% holdings.
They increased their short by these numbers of shares 280K, 305K, 225K, 260K, 230K and then a couple of days ago (22 Feb) they reduced their short by 385K (the highest amount)...

rxdav...while Jupiter continue to exit there will be all sorts of games played to get hold of some shares. I'm sure they're on the blower to II's still holding who came in below these levels to see if they will sell a couple of million. They will also go after Stop Losses and Limit Orders so I wouldn't be surprised to see a quick spike or two. As you say we should know more from the Short T update...
Meantime today most eyes are on the Ukranian situation...what a mess that is...

Looking at sells yesterday they might have access to between 600,000 and 800,000 today but as yesterday their buying is putting pressure on SP in upward direction.

To fully clear they need to purchase 2,235,200 shares (0.88%)...at yesterdays rate it will take about 5 days...personally think it will be slower unless they decide to take an SP rise hit just to clear...

Affraid I don't think Avacta will RNS or news this as the work was done in conjunction with Leeds Uni...but still a huge tick for the effectiveness of Affimers in the treatment of cancer and should strengthen work being done by Avacta and their partners...plus it published articles like this do give affimers more visibility within the overall scientific world and ultimately pharma etc...

Who would lend shares to someone else knowing they would sell them to knowingly try and drive the SP down so they could buy back the same number of shares cheaper to give back to the person who loaned them after taking the profit...? The person loaning now has their shares back but at a much lower value!!
Perhaps it's more likely the Boohoo guys simply selling some knowing they will be bought by new IIs attending the 3 day roadshow and once the price fell low enough the Boohoo guys start buying up the shares being sold by scared PIs...
Net result...new IIs get in, Boohoo guys end up with a bigger holding than they had or the same holding but having realised a bit of profit to help oil the wheels while until new LFT comes to market.
One think is for sure in my mind..this is not a straight short...there is a lot more to this one and we will probably never know if TR's aren't forthcoming and/or thresholds aren't crossed.
So far we have not had any TRs for movements up or down so it does look like existing IIs are holding but that's not to say they haven't done a bit of trading with a net result after orders have been completed keeping them within their reporting thresholds.
Personally, so far it looks pretty good to me...we've had the negative RNS...now all we need are the positive ones to come...

Mr R....'The way to close a short is to buy the share back,..'
and to close a large short in one hit is extremely difficult if the shares aren't readily available so it has to be worked. They will know how much they want to close out (all or part) and like many companies they won't necessarily report the close amount until they have completed all the transactions necessary to complete the close amount they set. Just like large buyers working through a large order and not reporting via TR1 until the whole order is completed.

Jupiter got shafted with SNG...it would make sense for them to get out of here (in whole or in part) while the going is good.
As I said before...where do you get a shed load of shares from when there aren't any new ones being issued...orchestrate a huge SP drop on the back of a negative RNS and hope enough PIs will sell in panic plus some stop losses taken out on the way down too.
If Jupiter is getting out then watch out you itsy bitsy shorters because once the deal has been done it will spring back like kn..ker elastic with a well timed RNS incoming...
AND how and what happened during 3 days of chatting to a bunch of new IIs ...
Large chunks of shares don't come easy you gotta work the room...and they've been working it...
Oh the games...

Tomorrow a bunch of LFT manufacturers will loose their ability to selling in the UK as they will no longer maintain their pre-approval extension...will the few companies who now have approval (assuming they can effectively detect Omicron) be able to cover demand going forward.

Surprised SNG trial allowed for other newly developed/re-assigned drugs to be administered...it truly changed the goal posts for them when it came to assessing the trial results.
Our trial is different so no need to get spooked...

Note the wording...A RANGE OF IVD ASSAYS...
'The role includes planning, performance and reporting of work to develop, optimise and validate a range of IVD assays, under the guidance of the ADPL'

Profcheese...I think the first time it came to light was on the Mologic MSD (safety sheet) was found and posted on here. At first it didn't mention Affimer and when this was questioned the updated it and made reference to affimer and Avacta but they kept the reference to the antibody coating even after several emails asking if this was a mistake. They never changed.
So anyone who reads this BB should not have been surprised as it was highlighted on here.

'The cheaper, faster tests tend to work by detecting specific proteins, collectively termed antigens, on the surface of SARS-CoV-2 particles. These ‘rapid antigen tests’ don’t amplify what’s in the sample, so can detect the virus only when it reaches a high level in a person’s body — with perhaps hundreds of thousands or millions of viral copies per millilitre of sample. The virus usually reaches these levels around the time that symptoms start, when people are at their most contagious'

Avacta have been honest about their test and have always said it only detects when the viral load is high...however, there is still a lower end when load becomes high and that's where they have always indicated our test sits...it is not a PCR test and no LFTs detect Covid a low viral load levels.
Our test has proved it's not the affimer that has been the issue so what does that say about non-affimer based LFTs...

rxdave...if they buy less than 3% they won't need to issue a TR1...
Some may choose to stay under the radar...

rxdave...if they buy less than 3% they won't need to issue a TR1...
Some may choose to stay under the radar...